日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Influence of MRI fusion biopsy on treatment recommendations : How reliable are biopsy results?]

【MRI融合活检对治疗方案建议的影响:活检结果的可靠性如何?】

Schildhauer, P; Müller, M; Merseburger, A S; Weiler, S M; Fürschke, A; Elser, Y; Moderegger, A; Fender, H E

SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy

SAUL 是一项单臂研究,旨在评估阿特珠单抗治疗既往接受过化疗的局部晚期或转移性泌尿系统癌的疗效:根据关键基线因素、PD-L1 表达和既往铂类药物治疗情况分析疗效。

Bamias, A; Merseburger, A S; Loriot, Y; James, N; Choy, E; Castellano, D; Lopez-Rios, F; Calabrò, F; Kramer, M; de Velasco, G; Zakopoulou, R; Tzannis, K; Sternberg, C N

[Treatment of oligo- and advanced metastatic prostate cancer]

[少突胶质细胞癌和晚期转移性前列腺癌的治疗]

Hadaschik, B A; Merseburger, A S

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma

Hsa-mir-124-3 CpG岛甲基化与透明细胞肾细胞癌患者的晚期肿瘤和疾病复发相关

Gebauer, K; Peters, I; Dubrowinskaja, N; Hennenlotter, J; Abbas, M; Scherer, R; Tezval, H; Merseburger, A S; Stenzl, A; Kuczyk, M A; Serth, J

Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.

通过组织芯片分析和血清水平测量,研究肾细胞癌中 bFGF 表达与临床和组织病理学特征的相关性

Horstmann M, Merseburger A S, von der Heyde E, Serth J, Wegener G, Mengel M, Feil G, Hennenlotter J, Nagele U, Anastasiadis A, Bokemeyer C, Stenzl A, Kuczyk M